Literature DB >> 10449437

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.

Z Y Jiang1, Y W Lin, A Clemont, E P Feener, K D Hein, M Igarashi, T Yamauchi, M F White, G L King.   

Abstract

Both insulin resistance and hyperinsulinemia have been reported to be independent risk factors for cardiovascular diseases. However, little is known regarding insulin signaling in the vascular tissues in insulin-resistant states. In this report, insulin signaling on the phosphatidylinositol 3-kinase (PI 3-kinase) and mitogen-activated protein (MAP) kinase pathways were compared in vascular tissues of lean and obese Zucker (fa/fa) rats in both ex vivo and in vivo studies. Ex vivo, insulin-stimulated tyrosine phosphorylation of insulin receptor beta subunits (IRbeta) in the aorta and microvessels of obese rats was significantly decreased compared with lean rats, although the protein levels of IRbeta in the 2 groups were not different. Insulin-induced tyrosine phosphorylation of insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) and their protein levels were decreased in the aorta of obese rats compared with lean rats. The association of p85 subunit to the IRS proteins and the IRS-associated PI 3-kinase activities stimulated by insulin in the aorta of obese rats were significantly decreased compared with the lean rats. In addition, insulin-stimulated serine phosphorylation of Akt, a downstream kinase of PI 3-kinase pathway, was also reduced significantly in isolated microvessels from obese rats compared with the lean rats. In euglycemic clamp studies, insulin infusion greatly increased tyrosine phosphorylation of IRbeta- and IRS-2-associated PI 3-kinase activity in the aorta of lean rats, but only slight increases were observed in obese rats. In contrast, insulin stimulated tyrosine phosphorylation of MAP kinase (ERK-1/2) equally in isolated microvessels of lean and obese rats, although basal tyrosine phosphorylation of ERK-1/2 was higher in the obese rats. To our knowledge, these data provided the first direct measurements of insulin signaling in the vascular tissues, and documented a selective resistance to PI 3-kinase (but not to MAP kinase pathway) in the vascular tissues of obese Zucker rats.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449437      PMCID: PMC408521          DOI: 10.1172/JCI5971

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.

Authors:  S J Kim; C R Kahn
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells.

Authors:  P W Anderson; X Y Zhang; J Tian; J D Correale; X P Xi; D Yang; K Graf; R E Law; W A Hsueh
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

3.  Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

Authors:  G Zeng; M J Quon
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.

Authors:  F Ahmad; J L Azevedo; R Cortright; G L Dohm; B J Goldstein
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

5.  Mechanism of free fatty acid-induced insulin resistance in humans.

Authors:  M Roden; T B Price; G Perseghin; K F Petersen; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis.

Authors:  A Avignon; K Yamada; X Zhou; B Spencer; O Cardona; S Saba-Siddique; L Galloway; M L Standaert; R V Farese
Journal:  Diabetes       Date:  1996-10       Impact factor: 9.461

8.  Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.

Authors:  T S Pillay; S Xiao; J M Olefsky
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.

Authors:  G Howard; D H O'Leary; D Zaccaro; S Haffner; M Rewers; R Hamman; J V Selby; M F Saad; P Savage; R Bergman
Journal:  Circulation       Date:  1996-05-15       Impact factor: 29.690

10.  Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.

Authors:  D Worm; A Handberg; E Hoppe; J Vinten; H Beck-Nielsen
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

View more
  174 in total

1.  Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats.

Authors:  H G Zecchin; R M N Bezerra; J B C Carvalheira; M A Carvalho-Filho; K Metze; K G Franchini; M J A Saad
Journal:  Diabetologia       Date:  2003-04-05       Impact factor: 10.122

Review 2.  Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

3.  Pioglitazone attenuates prostatic enlargement in diet-induced insulin-resistant rats by altering lipid distribution and hyperinsulinaemia.

Authors:  Ajit Vikram; Gopabandhu Jena; Poduri Ramarao
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 4.  Muscle microvasculature's structural and functional specializations facilitate muscle metabolism.

Authors:  Yvo H A M Kusters; Eugene J Barrett
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

5.  Insulin resistance: Is it time for primary prevention?

Authors:  Valentina Mercurio; Guido Carlomagno; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-01-26

6.  Prevention of hyperglycemic signal pathways in metabolic syndrome carotid artery of rats.

Authors:  Hiromi Kawai; Fengfeng Tian; Tomoko Kurata; Kentaro Deguchi; Toru Yamashita; Yoshio Omote; Syoichiro Kono; Koji Abe
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

Review 7.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

Review 8.  Endothelial dysfunction in human diabetes.

Authors:  Sari Mäkimattila; Hannele Yki-Järvinen
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  The response of glucose-excited neurones in the ventromedial hypothalamus to decreased glucose is enhanced in a murine model of type 2 diabetes mellitus.

Authors:  V E Cotero; B B Zhang; V H Routh
Journal:  J Neuroendocrinol       Date:  2009-12-04       Impact factor: 3.627

10.  Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans.

Authors:  Amale A Lteif; Angie D Fulford; Robert V Considine; Inessa Gelfand; Alain D Baron; Kieren J Mather
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-28       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.